CORCORAN E THOMAS
SEC Form 4 insider trading activity
CORCORAN E THOMAS has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, CORCORAN E THOMAS is listed as Director at PHIBRO ANIMAL HEALTH CORP. Inside the rolling window, CORCORAN E THOMAS reported 1 open-market purchase totaling $318K in PAHC and no open-market sales.
Companies traded
Other insiders at PAHC
Insider Buying
$318K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has CORCORAN E THOMAS made?
CORCORAN E THOMAS has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does CORCORAN E THOMAS trade?
CORCORAN E THOMAS has filed SEC Form 4 disclosures for 1 company, including PAHC.
When was CORCORAN E THOMAS's most recent SEC Form 4 filing?
CORCORAN E THOMAS's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is CORCORAN E THOMAS's total buy and sell value in the current window?
Inside the rolling retention window, CORCORAN E THOMAS bought $318K and sold $0 based on SEC Form 4 filings.
What was CORCORAN E THOMAS's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 PAHC shares on 2026-05-29, worth $318K, per SEC Form 4 filings.